Xcout IntelAMPLY Discovery
AMPLY Discovery is a biotechnology company based in the UK. This biotech firm focuses on developing a pipeline of first-in-class drugs by exploring the 98% of the genome largely ignored by other drug developers. It is headquartered in Belfast.
Subscribe to see AMPLY Discovery’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AMPLY Discovery at a glance
AMPLY Discovery is a biotech company headquartered in United Kingdom, founded in 2021. Xcout tracks 7 named people at AMPLY Discovery, including Prof Colin Lowdell (Chairman).
AMPLY Discovery leadership
- Prof Colin LowdellChairman
- Dr John CassidyCEO & Co-Founder
- Dr Catherine HarrisonCOO & Co-Founder
- Dr Sean CallananCSO & Co-Founder
- Dr Andy HartNon-Executive Director
- Dr Malcolm WeirNon-Executive Director
1 more named person on record for AMPLY Discovery, with roles, board committees and tenure — see the full roster →
AMPLY Discovery competitors
A few of AMPLY Discovery's closest competitors — see the full list of competitors and alternatives →
Amplica Bio, Inc. is a biotechnology company that develops next-generation biologics and therapies aimed at targeting difficult diseases. The company engages in drug engineering to address challenging therapeutic targets.
Argonaute RNA is a therapeutics company headquartered in Bristol, United Kingdom, pursuing opportunities in RNA-based treatments.
Harmonic Discovery is a drug discovery company founded in 2021 and headquartered in New York City. The company leverages machine learning and precision pharmacology to develop therapeutics for complex diseases.
cAMPfield Therapeutics is a biotechnology research company headquartered in San Diego, California. The company focuses on discovering and developing innovative therapeutic treatments targeting specific biological pathways.
Mironid Limited is a privately held drug discovery company founded in 2015 and headquartered in Glasgow, Scotland. The patient-focused company develops innovative therapeutics to improve the treatment of various medical conditions.
Cadenza Bio, Inc. is a privately held preclinical biotechnology company founded in 2022 and headquartered in Oklahoma City, dedicated to developing novel, non-steroidal, highly selective small-molecule therapies.
Get AMPLY Discovery's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AMPLY Discovery in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access